WEBULL
News
STEM
10.80
0.00%
0.00
Microbot Medical präsentiert LIBERTY-System auf SIO-Jahrestagung in Savannah
Reuters · 3d ago
Microbot Medical Showcases LIBERTY Robotic System at Society of Interventional Oncology Annual Meeting
Reuters · 3d ago
Microbot Medical präsentiert LIBERTY Endovascular Robotic System auf Konferenz der Society of Interventional Oncology
Reuters · 3d ago
Microbot Medical Showcases LIBERTY Endovascular Robotic System at Society of Interventional Oncology Conference
Reuters · 3d ago
MICROBOT MEDICAL CONTINUES ITS 2025 MOMENTUM; ANNOUNCES KEY 2026 MILESTONES
Reuters · 01/12 13:30
Microbot Medical and Emory University Hospital Launch Endovascular Robotics Program
Reuters · 11/26/2025 13:31
Emory University Hospital Adopts Microbot Medical's LIBERTY Endovascular Robotic System
Reuters · 11/26/2025 13:30
MICROBOT MEDICAL INC - FULL MARKET RELEASE EXPECTED AT SIR CONFERENCE IN APRIL 2026
Reuters · 11/05/2025 13:33
MICROBOT MEDICAL- LAUNCHES LIMITED MARKET RELEASE OF LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM IN US
Reuters · 11/05/2025 13:33
Microbot Medical Launches LIBERTY Robotic System in U.S. Market
Reuters · 11/05/2025 13:30
Microbot Medical Inc. Receives FDA 510(k) Clearance for LIBERTY® Endovascular Robotic System, Prepares for Q4 Commercial Launch
Reuters · 10/16/2025 12:30
Microbot Medical announces partnership with US logistics provider to support Liberty System commercialization
Reuters · 10/14/2025 12:30
MICROBOT MEDICAL INC FILES FOR OFFERING OF UP TO 14.7 MLN SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING
Reuters · 10/14/2025 10:27
Microbot Medical Announces $29.2 Million in Gross Proceeds from Private Placement, with Potential for Additional $63 Million Through New Series J Preferred Investment Options
Reuters · 10/07/2025 12:00
Microbot Medical Inc. Issues 600,000 Shares, 374,167 Shares in Preferred Option Exercises, and Grants New Series J Options in Recent Transactions
Reuters · 10/03/2025 20:31
MICROBOT MEDICAL INC - RECEIVES FIRST PATENT IN JAPAN FOR LIBERTY SYSTEM - SEC FILING
Reuters · 10/01/2025 13:02
Microbot Medical Secures First Japanese Patent for LIBERTY® Endovascular Robotic System, Expanding Global IP Portfolio
Reuters · 10/01/2025 13:00
Microbot Medical Inc. Announces Special One-Time Cash Bonuses and Amended Compensation for Executives and Non-Management Board Members
Reuters · 09/23/2025 15:38
Microbot Medical Inc. Receives FDA 510(k) Clearance for LIBERTY® Endovascular Robotic System Commercialization
Reuters · 09/23/2025 12:30
MIOCRBOT MEDICAL® CEO TO DISCUSS RECENT FDA CLEARANCE OF THE LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM
Reuters · 09/23/2025 12:30
More
Webull provides a variety of real-time STEM stock news. You can receive the latest news about Microbot Medical through multiple platforms. This information may help you make smarter investment decisions.
About STEM
Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms, ViRob, TipCAT and Liberty, including certain CardioSert assets, are comprised of proprietary technologies. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCSTM) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH). Utilizing the Liberty and CardioSert platforms, it is developing disposable robot for various endovascular interventional procedures. ViRob technology is an autonomous crawling micro-robot. TipCAT is a disposable self-propelled locomotive device. Liberty is a disposable robotic system.